{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:48:59Z","timestamp":1787870939931,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1428,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1469-0691.2010.03286.x","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T08:03:56Z","timestamp":1275984236000},"page":"25-33","source":"Crossref","is-referenced-by-count":37,"title":["Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach"],"prefix":"10.1016","volume":"17","author":[{"given":"S.","family":"Cicalini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Almodovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2010.03286.x_bib1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm.155.3.9117037","article-title":"HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study","volume":"155","author":"Opravil","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e3282f7cd42","article-title":"Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension","volume":"22","author":"Hsue","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0046-8177(87)80417-3","article-title":"Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome","volume":"18","author":"Kim","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.aids.0000327514.60879.47","article-title":"Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era","volume":"22","author":"Opravil","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary pulmonary hypertension in HIV infection","volume":"100","author":"Speich","year":"1991","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib10","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/QAD.0b013e328310161f","article-title":"Pulmonary arterial hypertension and HIV infection","volume":"22","author":"Cicalini","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1293.2008.00602.x","article-title":"Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary hypertension: results of the HIV-HEART Study","volume":"9","author":"Reinsch","year":"2008","journal-title":"HIV Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib12","first-page":"23","article-title":"Cardiovascular diseases and HIV infection: study of 79 cases at the National Hospital of Ouagadougou (Burkina Faso)","volume":"95","author":"Niakara","year":"2002","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib14","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.CIR.89.6.2722","article-title":"Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension","volume":"89","author":"Petitpretz","year":"1994","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib15","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib17","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","article-title":"The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0025-6196(12)65277-X","article-title":"Primary pulmonary hypertension: a histopathologic study of 80 cases","volume":"60","author":"Bjornsson","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1183\/09031936.06.00015206","article-title":"Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review","volume":"28","author":"Johnson","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clpt.2005.04.005","article-title":"Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers","volume":"78","author":"Glesby","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib23","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/338813","article-title":"Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors","volume":"34","author":"Petrosillo","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0300-8932(03)76889-4","article-title":"Treatment of HIV-associated pulmonary hypertension with treprostinil","volume":"56","author":"Cea-Calvo","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1753465808101549","article-title":"Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade","volume":"3","author":"Zac\u00e0","year":"2009","journal-title":"Ther Adv Respir Dis"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00002030-200109070-00026","article-title":"Sildenafil in HIV-related pulmonary hypertension","volume":"15","author":"Schumacher","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00002030-200207260-00021","article-title":"Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension","volume":"16","author":"Carlsen","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1754.2006.00816.x","article-title":"Sildenafil as treatment for human immunodeficiency virus-related pulmonary hypertension in a child","volume":"42","author":"Wong","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2125.2000.00245.x","article-title":"Pharmacokinetic interactions between sildenafil and saquinavir\/ritonavir","volume":"50","author":"Muirhead","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/000331979804901206","article-title":"Role of human immunodeficiency virus in primary pulmonary hypertension. Case reports","volume":"49","author":"Pellicelli","year":"1998","journal-title":"Angiology"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/157016209789973583","article-title":"Treatment and outcome of pulmonary arterial hypertension in HIV-infected patients: a review of the literature","volume":"7","author":"Cicalini","year":"2009","journal-title":"Curr HIV Res"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib36","doi-asserted-by":"crossref","first-page":"e6949","DOI":"10.1371\/journal.pone.0006949","article-title":"Evidence for limited genetic compartmentalization of HIV-1 between lung and blood","volume":"4","author":"Heath","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.0808501","article-title":"Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages","volume":"85","author":"Westhorpe","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib38","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib39","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/01.aids.0000176230.94226.06","article-title":"Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France","volume":"19","author":"Montani","year":"2005","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-0115(98)00069-X","article-title":"HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis","volume":"76","author":"Kim","year":"1998","journal-title":"Regul Pept"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","article-title":"Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins","volume":"333","author":"Kanmogne","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/CT:4:2:097","article-title":"HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signalling","volume":"4","author":"Fiala","year":"2004","journal-title":"Cardiovasc Toxicol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/j.1540-8167.2009.01713.x","article-title":"Reduction of ventricular sodium current in a mouse model of HIV","author":"Grandy","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12012-008-9026-y","article-title":"CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120","volume":"8","author":"Yuan","year":"2008","journal-title":"Cardiovasc Toxicol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib45","doi-asserted-by":"crossref","first-page":"H1672","DOI":"10.1152\/ajpheart.00955.2001","article-title":"Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage","volume":"282","author":"Raidel","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","article-title":"HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques","volume":"174","author":"Marecki","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03286.x_bib47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/MMBR.00042-05","article-title":"Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways","volume":"70","author":"Roeth","year":"2006","journal-title":"Microbiol Mol Biol Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:40:41Z","timestamp":1559155241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14609095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1198743X14609095"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03286.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}